期刊文献+

T细胞人类白细胞抗原-G过表达对T细胞共培养胃癌MGC-803细胞的免疫杀伤作用 被引量:2

Immune killing effect of HLA-G over expression on co-cultured gastric cancer MGC-803 cells
原文传递
导出
摘要 目的研究T细胞人类白细胞抗原-G(HLA-G)过表达后对共培养胃癌MGC-803细胞的免疫杀伤作用。方法处死各组小鼠后分离淋巴细胞,通过免疫磁珠纯化T淋巴细胞,其纯度用流式细胞仪测定。将转染试剂、NC质粒、HLA-G重组载体分别转染至T淋巴细胞分为对照(Control)组、NC转染组、HLA-G转染组,细胞转染效率用荧光显微镜和流式细胞仪测定。以蛋白质印迹(WB)法测定各组细胞中HLA-G蛋白表达水平;以酶联免疫吸附(ELISA)法测定各组细胞上清液中γ-干扰素(IFN-γ)、白细胞介素-2(IL-2)、肿瘤坏死因子-α(TNF-α)表达水平;转染48 h后以CCK-8法检测HLA-G转染组、NC转染组、Control组与胃癌MGC-803细胞共培养时肿瘤免疫杀伤效率。结果HLA-G转染组细胞中HLA-G蛋白表达(1.08±0.09)明显高于Control组(0.18±0.04)和NC转染组(0.17±0.05,P<0.05)。与Control组、NC转染组相比,HLA-G转染组细胞中IFN-γ、IL-2、TNF-α水平均明显降低(均P<0.05)。效靶比为10∶1、20∶1、40∶1时,与Control组、NC转染组相比,HLA-G转染组胃癌细胞免疫杀伤率均显著降低(P<0.05)。结论T细胞过表达HLA-G后可减弱对胃癌细胞MGC-803体外免疫作用,当效靶比为40∶1时,T细胞对胃癌细胞MGC-803免疫杀伤作用最显著。 Objective To explore the immune killing effect of human leukocyte antigen-G(HLA-G)overexpression on T cell co-cultured gastric cancer MGC-803 cells.Methods After the mice of each group were killed,lymphocytes were collected from the spleen,T cells were purified by immunomagnetic beads,the purity of T lymphocyte was detected by flow cytometry.The T lymphocytes was transfected by transfection reagent,NC plasmid and HLA-G recombinant vector were divided into control group,NC transfection group,HLA-G transfection group.Flow cytometry and fluorescence microscope were used to detect cell transfection efficiency.Western blotting(WB)was used to detect the expression of HLA-G protein in cells;the expressions of interferon-γ(IFN-γ),interleukin-2(IL-2)and tumor necrosis factor-α(TNF-α)were detected by enzyme linked immunosorbent assay(ELISA);CCK-8 assay was used to detect the tumor immune killing efficiencies of HLA-G transfection group,NC transfection group control group were co-cultured with gastric cancer MGC-803 cells after 48 h of transfection.Results The expression of HLA-G protein(1.08±0.09)in HLA-G transfection group was significantly higher than those in control group(0.18±0.04)and NC group(0.17±0.05,P<0.05).The levels of IFN-γ,IL-2,TNF-αin HLA-G transfection group were significantly lower than those in control group and NC group(P<0.05).Compared with control group and NC transfection group,the mmune killing rate of gastric cancer cells in HLA-G transfection group was significantly lower when the target-effect ratio were 10∶1,20∶1 and 40∶1(P<0.05).Conclusion Overexpression of HLA-G in T cells attenuates the immune effect of MGC-803 on gastric cancer cells in vitro,when the target-to-effect ratio was 40∶1,T cells had the most significant immune killing effect on gastric cancer cell line MGC-803.
作者 谭业儒 伍小平 李跃华 TAN Ye-ru;WU Xiao-ping;LI Yue-hua(Department of Internal Medicine-Oncology,The First Affiliated Hospital of University of South China,Hengyang 421001,Hunan Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2021年第2期133-135,149,共4页 The Chinese Journal of Clinical Pharmacology
关键词 T细胞 人类白细胞抗原-G 胃癌 免疫杀伤效率 T cells human leukocyte antigen-G gastric cancer immune killing effect
  • 相关文献

参考文献9

二级参考文献85

  • 1Atsushi Tashiro,Masatoshi Sano,Koichi Kinameri,Kazutaka Fujita,Yutaka Takeuchi.Comparing mass screening techniques for gastric cancer in Japan[J].World Journal of Gastroenterology,2006,12(30):4873-4874. 被引量:24
  • 2Ott K, Vogelsang H, Marton N, et al. The thymidylate synthase tandem repeat promoter polymorphism : A predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancer [ J]. Int J Cancer, 2006, 119(12) :2885 -2894.
  • 3Ruzzo A, Graziano F, Kawakami K, et al. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy [J]. J Clin Oncol, 2006,24(12) :1883 - 1891.
  • 4Lu JW, Gao CM, Wu JZ, et al. Polymorphism in the 3'- untranslated region of the thymidylate synthase gene and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy [J]. J Hum Genet, 2006,51 (3):155 - 160.
  • 5Koizumi W, Saigenji K, Nakamaru N, et al. Prediction of response to 5'-deoxy-5-fluorouridine ( 5'-DFUR ) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet- derived endothelial cell growth factor [ J ]. Oncology, 1999,56 ( 3 ) :215 - 222.
  • 6Terashima M, Fujiwara H, Takagane A, et al. Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridinc in gastric cancer patients [ J ]. Eur J Cancer, 2002,38 ( 18 ) : 2375 - 2381.
  • 7Terashima M, Fujiwara H, Takagane A, et al. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer [J]. Gastric Cancer, 2003,6(Suppl 1) :71 -81.
  • 8Nishina T, Hyodo I, Miyaike J, et al. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 50-deoxy-5-fluorouridine [ J]. Eur J Cancer, 2004,40(10) : 1566 - 1571.
  • 9Terashima M, Irinoda T, Fujiwara H, et al. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5- fluorouraeil in human gastric cancer [ J ]. Anticaneer Res, 2002,22(2A) :761 -768.
  • 10Yeh KH, Shun CT, Chen CL, et al. High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy [ J ]. Cancer, 1998,82 (9) : 1626 - 1631.

共引文献1102

同被引文献22

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部